argenx SE (1AE)
XETR
Real-time Data
07:00 AM
Day's Range
871.8052 wk Range
574.20Overview - 1AE - argenx SE
Key Statistics
Valuation
Enterprise Value
42.69B
Price / Book
‪7.63‬
EV / EBITDA
‪30.90‬
Profitability
Profit Margin
‪32.26%‬
Operating Margin
‪31.99%‬
Return on Assets
‪11.63%‬
Return on Equity
‪23.63%‬
Ownership
Float
62.42M
Held by Insiders
‪0.01%‬
Held by Institutions
‪48.04%‬
Price stats
Beta
‪-0.04‬
50-Day Avg
‪785.62‬
200-Day Avg
‪723.63‬
Peers - 1AE - argenx SE
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- 1AEXETRargenx SE+11.11%52-week change—P/E (Trailing)‪32.26%‬Profit Margin
- ANLXETRAnalog Devices, Inc.+32.98%52-week change44.45P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna, Inc.+82.35%52-week change-16.82P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE+7.70%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG+42.52%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- 2X1XETRAbivax SA+26.30%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- A1P0XETRDefiance AI & Power Infrastructure ETF+12.80%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 1AE - argenx SE
About
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
